KieronDunleavyMD

PubMed

• Vaccination of Adults With Cancer: ASCO Guideline.
  Mini Kamboj, Kari Bohlke, Deana M Baptiste, Kieron Dunleavy, Abbey Fueger, Lee Jones, Amar H Kelkar, Lisa Y Law, Kristine B LeFebvre, Per Ljungman, Eric D Miller, Lari...> ;Journal of Clinical Oncology. 2024 Mar 18
• 1 citations
  Improved survival for dose-intensive chemotherapy in primary mediastinal B-cell lymphoma: a systematic review and meta-analysis of 4,068 patients.
  Michael R Cook, Lacey S Williams, Charles Scott Dorris, Yutong Luo, Kepher Makambi, Kieron Dunleavy> ;Haematologica. 2024 Mar 1
• Prognostic factors for adult patients with Burkitt lymphoma treated with dose-adjusted EPOCH-R.
  Rahul Lakhotia, Kieron Dunleavy, Jeremy S Abramson, Brian K Link, Bayard L Powell, Christopher Melani, Andrea N Lucas, Seth M Steinberg, Jonathan W Friedberg, Brad S K...> ;Blood Advances. 2023 Sep 26
• 1 citations
  Chimeric antigen receptor (CAR) T cells for the treatment of a kidney transplant patient with post-transplant lymphoproliferative disorder (PTLD).
  Kathryn Kline, Wengen Chen, Michael E Kallen, Rima Koka, Destiny Omili, Xiaoxuan Fan, Thierry Iraguha, Etse Gebru, Nishanthini Dishanthan, Jillian M Baker, Kenneth A D...> ;Human Vaccines & Immunotherapeutics. 2023 Aug 1
• 1 citations
  Interferon alfa-2b in patients with low-grade lymphomatoid granulomatosis and chemotherapy with DA-EPOCH-R in patients with high-grade lymphomatoid granulomatosis: an ...
  Christopher Melani, Kennichi Dowdell, Stefania Pittaluga, Kieron Dunleavy, Mark Roschewski, Joo Y Song, Sara Calattini, Jun-Ichi Kawada, David A Price, Pratip K Chatto...> ;The Lancet. Haematology. 2023 May 1
• 23 citations
  Toxicity and efficacy of CAR T-cell therapy in primary and secondary CNS lymphoma: a meta-analysis of 128 patients.
  Michael R Cook, C Scott Dorris, Kepher H Makambi, Yutong Luo, Pashna N Munshi, Michelle Donato, Scott Rowley, Ayman Saad, Andre Goy, Kieron Dunleavy, Alaa Ali> ;Blood Advances. 2023 Jan 10
• Multiple myeloma with central nervous system relapse presenting as right pupil-sparing complete third nerve palsy.
  Andrew Tiu, Jennifer Marks, Roaa Aljuaid, Ali Alzeer, Kieron Dunleavy> ;American Journal of Hematology. 2022 Dec 1
• 54 citations
  Genomic profiling for clinical decision making in lymphoid neoplasms.
  Laurence de Leval, Ash A Alizadeh, P Leif Bergsagel, Elias Campo, Andrew Davies, Ahmet Dogan, Jude Fitzgibbon, Steven M Horwitz, Ari M Melnick, William G Morice, Ryan ...> ;Blood. 2022 Nov 24
• 8 citations
  CAR T-cell therapy in highly aggressive B-cell lymphoma: emerging biological and clinical insights.
  Alaa Ali, Andre Goy, Kieron Dunleavy> ;Blood. 2022 Sep 29
• 12 citations
  Circulating tumor DNA predicts therapeutic outcome in mantle cell lymphoma.
  Rahul Lakhotia, Christopher Melani, Kieron Dunleavy, Stefania Pittaluga, Nakhle Saba, Liza Lindenberg, Esther Mena, Ethan Bergvall, Andrea Nicole Lucas, Allison Jacob,...> ;Blood Advances. 2022 Apr 26
• 2 citations
  Targeting The Tumor Microenvironment in Lymphomas: Emerging Biological Insights and Therapeutic Strategies.
  Michael R Cook, Kieron Dunleavy> ;Current Oncology Reports. 2022 Sep 1
• 14 citations
  Double-hit lymphoma: optimizing therapy.
  Kieron Dunleavy> ;Hematology. American Society of Hematology. Education Program. 2021 Dec 10
• 1 citations
  Optimizing outcomes in primary mediastinal B-cell lymphoma: is R-CHOP enough?
  Michael R. Cook, Kieron Dunleavy> ;Blood Advances. 2021 Oct 12
• 7 citations
  Novel Biological Insights and New Developments in Management of Burkitt Lymphoma and High-Grade B-Cell Lymphoma.
  Coen J Lap, Samah Nassereddine, Kieron Dunleavy> ;Current Treatment Options in Oncology. 2021 Jun 7
• 30 citations
  Safety and efficacy of navitoclax, a BCL-2 and BCL-XL inhibitor, in patients with relapsed or refractory lymphoid malignancies: results from a phase 2a study.
  Sven de Vos, John P. Leonard, Jonathan W. Friedberg, Jasmine Zain, Kieron Dunleavy, Rod A. Humerickhouse, John Hayslip, John Pesko, Wyndham H Wilson> ;Leukemia & Lymphoma. 2021 Mar 21
• 11 citations
  Primary Central Nervous System Lymphoma: Evolving Biologic Insights and Recent Therapeutic Advances
  Dai Chihara, Kieron Dunleavy> ;Clinical Lymphoma, Myeloma & Leukemia. 2021 Feb 1
• 31 citations
  Consensus Guidelines for Evaluation and Management of Pulmonary Disease in Sjögren's.
  Augustine S. Lee, R. Hal Scofield, Katherine M. Hammitt, Nishant Gupta, Donald E. Thomas, Teng Moua, Kamonpun Ussavarungsi, E. William St. Clair, Richard T. Meehan, Ki...> ;Chest. 2021 Feb 1
• 13 citations
  How I treat lymphoma in pregnancy
  Kieron Dunleavy, Claire McLintock> ;Blood. 2020 Nov 5
• 65 citations
  Multicenter Study of Risk-Adapted Therapy With Dose-Adjusted EPOCH-R in Adults With Untreated Burkitt Lymphoma
  Mark Roschewski, Kieron Dunleavy, Jeremy S. Abramson, Bayard L. Powell, Brian K. Link, Prapti A. Patel, Philip J. Bierman, Deepa Jagadeesh, Ronald T. Mitsuyasu, David ...> ;Journal of Clinical Oncology. 2020 May 26
• 1 citations
  Tackling Burkitt when it's back.
  Aron Simkins, Kieron Dunleavy> ;Blood. 2020 Apr 2
• Epigenetic targeting in mantle cell lymphoma
  Kieron Dunleavy> ;British Journal of Haematology. 2019 Sep 1
• 2 citations
  Hybrid dosing of the cyclin-dependent kinase (CDK) inhibitor flavopiridol in relapsed/refractory mantle cell lymphoma and diffuse large B-cell lymphoma.
  Milos D. Miljkovic, Mark Roschewski, Kieron Dunleavy, Wyndham H. Wilson> ;Leukemia & Lymphoma. 2019 Jun 17
• 9 citations
  Burkitt Lymphoma and Other High-Grade B-Cell Lymphomas with or without MYC, BCL2, and/or BCL6 Rearrangements
  Rami Alsharif, Kieron Dunleavy> ;Hematology/oncology Clinics of North America. 2019 May 24
• 6 citations
  Development of Hepatic Steatosis After Chemotherapy for Non-Hodgkin Lymphoma.
  Gil Ben-Yakov, Hawwa Alao, John P. Haydek, Nancy Fryzek, Min Ho Cho, Mehdi Hemmati, Vikram Samala, Margaret Shovlin, Kieron Dunleavy, Wyndham H. Wilson, Elizabeth C. J...> ;Hepatology Communications. 2019 Feb 1
• 120 citations
  Dose-adjusted EPOCH-R (etoposide, prednisone, vincristine, cyclophosphamide, doxorubicin, and rituximab) in untreated aggressive diffuse large B-cell lymphoma with MYC...
  Kieron Dunleavy, Michelle A. Fanale, Jeremy S. Abramson, Ariela Noy, Paolo Caimi, Stefania Pittaluga, Samir Parekh, Ann S. LaCasce, John Hayslip, Deepa Jagadeesh, Suni...> ;The Lancet. Haematology. 2018 Dec 1
• Join now to see all